Volumetric assessment in malignant pleural mesothelioma

被引:16
|
作者
Murphy, David J.
Gill, Ritu R.
机构
[1] Brigham & Womens Hosp, Dept Radiol, Div Thorac Imaging, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
关键词
Mesothelioma; CT; volume; volumetric CT; malignant pleural mesothelioma (MPM); POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; THERAPY RESPONSE; MODIFIED RECIST; TUMOR RESPONSE; LUNG-CANCER; FDG-PET/CT; SURVIVAL; CT;
D O I
10.21037/atm.2017.05.23
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant pleural mesothelioma (MPM) is a highly malignant pleural neoplasm with a dismal prognosis. Multimodality approach including surgery and chemotherapy are utilized to treat patients with resectable disease. Clinical staging allows for selection of patients for treatment strategies, but has not been found to be prognostic and is plagued by high interobserver variability. Tumor volume measurement on cross-sectional imaging has emerged as a potential quantitative tool with prognostic significance. This review focuses on volumetric assessment from cross-sectional imaging (CT, MRI, F-18-FDG PET/CT) and the potential prognostic benefit and applications.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] A COMPARISON OF CT AND MRI VOLUMETRIC ASSESSMENT OF MALIGNANT PLEURAL MESOTHELIOMA
    Tsim, S.
    Cowell, G. W.
    Kidd, A.
    Woodward, R.
    Alexander, L.
    Kelly, C.
    Foster, J. E.
    Blyth, K. G.
    THORAX, 2019, 74 : A80 - A81
  • [2] Novel Magnetic Resonance Imaging Methodology for the Volumetric Assessment of Malignant Pleural Mesothelioma
    Tsim, S.
    Cowell, G. W.
    Woodward, R.
    Alexander, L.
    Kelly, C.
    Foster, J. E.
    Blyth, K. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [3] The role of volumetric method in the assessment of chemotherapy response and predicting survival in malignant pleural mesothelioma
    Urfali, Furkan Erturk
    Metintas, Selma
    Gurgen, Atila
    Guntulu, A. K.
    Ozkan, Ragip
    Metintas, Muzaffer
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (01) : 69 - 74
  • [4] NOVEL CLINICAL ASSESSMENT OF MALIGNANT PLEURAL MESOTHELIOMA
    Gill, Ritu R.
    Richards, William
    Yeap, Beow Y.
    Bueno, Raphael
    Sugarbaker, David J.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S939 - S939
  • [5] Assessment of tumor response in malignant pleural mesothelioma
    Ceresoli, Giovanni L.
    Chiti, Arturo
    Zucali, Paolo A.
    Cappuzzo, Federico
    De Vincenzo, Fabio
    Cavina, Raffaele
    Rodari, Marcello
    Poretti, Dario
    Lutman, Fabio Romano
    Santoro, Armando
    CANCER TREATMENT REVIEWS, 2007, 33 (06) : 533 - 541
  • [6] A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma
    Rusch, Valerie W.
    Gill, Ritu
    Mitchell, Alan
    Naidich, David
    Rice, David C.
    Pass, Harvey I.
    Kindler, Hedy L.
    De Perrot, Marc
    Friedberg, Joseph
    ANNALS OF THORACIC SURGERY, 2016, 102 (04): : 1059 - 1066
  • [7] Malignant pleural mesothelioma
    Rao, D. Pragati
    Vijayan, Sruthy
    Vananjakar, Shashidhar S.
    Kumar, T. Prasanna
    BMJ CASE REPORTS, 2025, 18 (02)
  • [8] Malignant pleural mesothelioma
    Hughes, RS
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 329 (01): : 29 - 44
  • [9] Malignant pleural mesothelioma
    Schouwink, H
    Baas, P
    Rutgers, ETH
    Zoetmulder, FAN
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (03) : 706 - 706
  • [10] MALIGNANT PLEURAL MESOTHELIOMA
    FISHMAN, L
    JOURNAL OF THE MAINE MEDICAL ASSOCIATION, 1978, 69 (03): : 70 - 71